Guide contents
Open in calculatorCompound briefing
Epitalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide developed from epithalamin, a peptide isolated from the bovine pineal gland. It has been studied for telomerase activation, telomere elongation, melatonin-axis normalisation and broader geroprotective effects in animal and early human research.
The research question
Epitalon is studied at the intersection of pineal signalling, circadian regulation and cellular ageing. Telomere-related measurements, melatonin rhythms and lifespan claims describe very different levels of evidence and should not be conflated.
Mechanism & research themes
Activates telomerase in somatic cells via regulation of the hTERT gene, potentially elongating telomeres and extending cellular replicative lifespan. Also normalises pineal melatonin secretion and modulates gene expression patterns associated with ageing.
Telomerase activation and telomere lengthening in cell and animal models
Normalisation of pineal melatonin secretion and circadian rhythms
Improved antioxidant enzyme status in ageing research
Potential extension of healthy lifespan markers in animal studies
Support for immune and neuroendocrine function in older subjects
Favourable tolerability profile across reported research
These are research themes reported across the literature, not established benefits or indications.
Evidence assessment
Small human reports and animal studies sit alongside cell findings, with limited independent replication. Telomerase activation is a mechanistic observation, not evidence of extended human lifespan.
What to look for
Controlled design, a defined preparation, clinically relevant endpoints and independent replication carry more weight than a single mechanism study.
What not to assume
A plausible pathway does not establish efficacy. Results across different routes, formulations and populations are not automatically interchangeable.
Protocol literature
Commonly referenced research protocols use 5–10mg subcutaneously once daily, typically for 10–20 consecutive days, followed by a 4–6 month break before repeating. Some longevity protocols use 2–3 short courses per year.
Reported persistence
Plasma half-life is short (minutes); functional effects are believed to persist through gene-expression and telomerase changes rather than direct receptor occupancy.
Calculator starting point
10 mg per reference dose
7 doses per week · 2-week cycle
1 mL default reconstitution volume
10 mg/day SC for 10–20 days; repeat course every 4–6 months.
Calculator defaults are editable mathematical reference values, not dosing advice. Verify all calculations independently.
Calculate EpitalonLaboratory handling
Reconstitution reference
Reconstitute a 10mg vial with 1–2mL bacteriostatic water for a 5–10mg/mL working concentration. Swirl gently.
Storage reference
Lyophilised: 2–8°C, stable 18–24 months. Reconstituted: 2–8°C, protect from light, use within 30 days.
Minimum documentation standard
- Record the lot identifier and review its matching analytical documentation.
- Use aseptic technique and record diluent, final volume and calculated concentration.
- Label preparation date, storage conditions and any light or freeze–thaw restrictions.
- Inspect before each use and investigate unexpected colour, clarity or particulate changes.
Limitations & safety
Human RCT data is limited and primarily from Russian-language literature.
Effects require repeated short courses rather than continuous daily use.
Long-term safety and optimal dosing intervals are not well established.
Research use only
This field note is an educational literature summary, not medical advice or a recommendation for human use. Safety statements are limited by the quality and duration of the available evidence.
Continue reading